Risk Communication and Informed Consent in the Medical Tourism Industry: A Thematic Content Analysis of Canadian Broker Websites by Penney, Kali et al.
RESEARCH ARTICLE Open Access
Risk communication and informed consent in the
medical tourism industry: A thematic content
analysis of canadian broker websites
Kali Penney1, Jeremy Snyder2*, Valorie A Crooks3 and Rory Johnston3
Abstract
Background: Medical tourism, thought of as patients seeking non-emergency medical care outside of their home
countries, is a growing industry worldwide. Canadians are amongst those engaging in medical tourism, and many
are helped in the process of accessing care abroad by medical tourism brokers - agents who specialize in making
international medical care arrangements for patients. As a key source of information for these patients, brokers are
likely to play an important role in communicating the risks and benefits of undergoing surgery or other procedures
abroad to their clientele. This raises important ethical concerns regarding processes such as informed consent and
the liability of brokers in the event that complications arise from procedures. The purpose of this article is to
examine the language, information, and online marketing of Canadian medical tourism brokers’ websites in light of
such ethical concerns.
Methods: An exhaustive online search using multiple search engines and keywords was performed to compile a
comprehensive directory of English-language Canadian medical tourism brokerage websites. These websites were
examined using thematic content analysis, which included identifying informational themes, generating frequency
counts of these themes, and comparing trends in these counts to the established literature.
Results: Seventeen websites were identified for inclusion in this study. It was found that Canadian medical tourism
broker websites varied widely in scope, content, professionalism and depth of information. Three themes emerged
from the thematic content analysis: training and accreditation, risk communication, and business dimensions. Third
party accreditation bodies of debatable regulatory value were regularly mentioned on the reviewed websites, and
discussion of surgical risk was absent on 47% of the websites reviewed, with limited discussion of risk on the
remaining ones. Terminology describing brokers’ roles was somewhat inconsistent across the websites. Finally,
brokers’ roles in follow up care, their prices, and the speed of surgery were the most commonly included business
dimensions on the reviewed websites.
Conclusion: Canadian medical tourism brokers currently lack a common standard of care and accreditation, and
are widely lacking in providing adequate risk communication for potential medical tourists. This has implications
for the informed consent and consequent safety of Canadian medical tourists.
Background
Medical tourism is a practice whereby patients travel
outside of their home country in order to receive medi-
cal care. The medical tourism industry is perceived as
rapidly expanding, though precise numbers on patient
flows are unknown [1]. For the purposes of this paper,
we understand medical tourism to entail patients travel-
ing internationally outside of established cross-border
care arrangements with accessing medical care as their
primary goal, which is usually paid for out of pocket [1].
Patients may decide to pursue medical treatment abroad
for any number of reasons, including a desire to gain
access to treatments that are not approved or are other-
wise available at home, the cost of treatment, and the
length of treatment wait times [2]. With smaller, elective
procedures it may be the draw of the destination itself
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or the anonymity provided by going abroad that moti-
vates patient travel [3].
Recently, there have been widely publicized reports in
the popular press about medical tourists dying or suffer-
ing complications from their surgeries [4-6]. In late
2010, Mahir Mostic, a 35 year old man from Ontario,
Canada traveled to Costa Rica to receive the controver-
sial ‘liberation therapy’ for multiple sclerosis and suf-
fered complications from the surgery. He returned to
Costa Rica for follow up care but subsequently died [4].
A woman from Alberta, Canada traveled abroad for
breast augmentation in 2010, and returned home with a
serious infection that resulted in the eventual loss of the
majority of her breast tissue [5]. Cases like these illus-
trate the possible negative outcomes faced by medical
tourists. Any surgery carries with it a certain degree of
risk; there is always the possibility of anaesthesia com-
plications, blood clots, uncontrolled bleeding and
human error during surgery as well as delayed healing
and infection after surgery [1]. Medical tourism, how-
ever, carries with it additional risks, including communi-
cation gaps between the physician and patient, taking
lengthy flights post-operatively, exposure to medical
malpractice abroad, difficulties obtaining follow up care,
and the danger of infectious disease transmission,
among others [1].
A highly visible and influential resource available to
patients thinking about going abroad for medical care is
the medical tourism broker. For the purpose of this
paper a broker is defined as a third party who connects
patients to hospitals or doctors in another country. Bro-
kers play a unique role in the practice of medical tour-
ism, and yet remain largely unregulated and poorly
understood. The exact percentage of medical tourists
who choose to use these brokers’ services is unknown,
but it is thought that they are likely playing a significant
role in medical tourists’ health decision-making [7]. For
many medical tourists, a broker provides critical infor-
mation and services that would be difficult to acquire
independently, particularly when traveling to a foreign
country for the first time. Brokers can help make travel
arrangements, suggest physicians and facilities abroad,
book surgeries, assist in the transportation and transla-
tion of medical records, and help arrange for follow up
care and oversee postoperative complications [8,9].
The internet has made it possible for more people
than ever before to explore medical treatment options
abroad. The vast majority of brokers have a strong
online presence and their websites are an important tool
for patients seeking information about possible treat-
ments and destinations [10] as well as financing and
insurance information [11]. These websites are often the
first source of information that patients are exposed to
[1,7,11,12]. Therefore, the information about the benefits
and risks of engaging in medical tourism presented on
these sites may have a strong impact on whether or not
and how the prospective medical tourist pursues treat-
ment abroad [12]. While medical tourists working with
a broker will typically be given additional information
beyond what is available online [6], brokers’ websites
likely help form the patient’s first impression of medical
tourism.
Given the risks associated with surgery in general and
medical tourism in particular, it is imperative from the
standpoint of medical ethics to assess how patients
understand these risks and how they are communicated
to them by others, especially when coupled with the
increasing visibility of medical tourism as a global health
services practice. Informed consent is a central ethical
value in medical practice [13]. What currently remains
unknown is whether medical tourism broker’s websites
serve to enhance or undermine the capacity of potential
medical tourists to make informed choices about enga-
ging in this practice. While potential medical tourists
can avail themselves of other sources of information
[1,7], the central role of broker websites in forming
initial impressions of the safety of medical tourism
means that any failure of these sites to communicate
risks effectively would raise serious ethical concerns
[14]. In this article we examine Canadian medical tour-
ism brokers’ involvement in risk communication to pro-
spective patients via their websites in order to address
this knowledge gap. We accomplish this through con-
ducting a thematic content analysis of 17 English-lan-
guage brokerage websites. We seek specifically to
analyze the way brokers communicate risk via their pro-
motional websites and the potential impact of their web-
sites on informed consent for patients, which
contributes to the nascent literature examining brokers’
roles and responsibilities in medical tourism
[6,7,11,12,14].
Risk and Informed Consent in Medical Tourism
Effective communication is essential to medical practice,
and medical ethicists emphasize the importance of
informed consent as a dimension of effective communi-
cation [15]. Informed consent carries with it two levels
of moral responsibility on the part of the health profes-
sional: adequate information must be communicated to
the patient and the patient must understand the infor-
mation they receive in order to make an informed deci-
sion regarding treatment [13]. This is particularly
important when considering a medical procedure that is
inherently risky or poorly understood [16]. Because the
possibility of a negative treatment outcome is appealing
neither to the physician nor the patient, there is a ten-
dency to avoid direct discussion of risk, which can lead
to patients making decisions without having truly
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considered the risks involved [17]. Patient assessment of
risk is also subject to various biases that can undermine
the clear communication of these risks, making it
important to factor these biases into risk communica-
tion strategies [18].
Medical tourism expands the range of individuals giv-
ing patients health advice with the addition of MT bro-
kers and foreign care providers [1], thereby further
complicating the communication of risk to these
patients and thus ultimately compromising their ability
to achieve informed consent. Information about the
quality of care available abroad and the possible risks
involved in a procedure is important for the patient to
have and to understand [1]. While under normal cir-
cumstances patients may receive this information from
their family doctor or from a nurse or surgeon at a hos-
pital in their home country [18], medical tourists may
need to rely on additional sources of information [1,19].
As medical tourism involves travel to a foreign country
that patients and their families may be unfamiliar with,
this practice creates uncertainties not found in tradi-
tional treatment that may add additional risks and infor-
mational burdens [20]. Moreover, the choice to travel
abroad may strain relationships with the patient’s family
doctor and other local medical professionals, further
cutting off normal means of gaining medical advice [6].
Not only may risk communication be particularly
complicated in the case of medical tourism, but the nat-
ure of the risks that patients may be exposed to can also
be heightened. Long air travel has been shown to
increase a person’s risk of deep-vein thrombosis (DVT)
[21] and it is suspected that this risk is further increased
by having had recent surgery [22]. Communication
between medical tourists and health care professionals
abroad may be difficult if there is a language barrier,
thus limiting risk-related communication [23]. The qual-
ity of a hospital or of a physician’s training may be diffi-
cult to ascertain if the credentials are foreign to the
patient, further complicating patient understanding of
risk [24]. In the case of a physician’s error or hospital
negligence, it is often difficult to receive compensation
for malpractice in many countries [25]. Follow up care
for medical tourists is uniquely challenging as they will
be returning to their home country and may have diffi-
culty contacting the physician or surgical team abroad
should complications or questions arise post-operatively,
which can pose as a post-operative health risk [14].
These potential risk factors have been previously identi-
fied, and many of them are preventable.
Methods
To identify English-language Canadian medical tourism
brokerage websites for inclusion in this analysis, we first
compiled a listing of company names mentioned in
published media accounts of medical tourism and
reviewed for Canadian membership in the Medical
Tourism Association (MTA). Following this we searched
the identified company names in an internet search
engine to locate their websites. Next we ran a series
searches on two internet search engines, exhaustively
searching combinations of the keywords Canad*, medi-
cal, tour*, and surger* using Boolean operators. Twenty
two brokerages were initially identified using these stra-
tegies in summer of 2010. In reviewing their websites,
five were excluded from the study as they appeared to
be inactive (e.g., no current contact information), not
focused on medical tourism (e.g., were selling insurance
packages), or were not based in or operating out of
Canada.
Following identification of the websites for inclusion
in this analysis we performed a thematic content analy-
sis. Thematic content analysis involves generating fre-
quency counts of the dominant themes in a dataset that
can be used to guide a thematic approach to analysis,
which typically involves identifying themes within a
dataset and comparing those themes to the study pur-
pose and existing literature [26]. In keeping with this
approach, the websites were first reviewed in order to
develop a list of informational points that were com-
monly included. Additional informational points were
added to the listing based upon our focus on risk com-
munication and informed consent. Frequency counts of
these informational points were generated, which
formed the basis of the content component of our ana-
lysis. In reviewing the trends among the quantitative
counts and comparing these trends to the existing litera-
tures on medical tourism and informed consent, three
themes were identified for the thematic component of
the analysis. Following identification of these themes,
consensus was sought among the team members to
ensure confirmation of this interpretation. Data relevant
to each of these themes were then compiled from the
websites included in the study and reviewed again in
order to focus the analysis.
Results
A summary of the websites included in this analysis can
be found in Table 1. A summary of the counts gener-
ated for the thematic content analysis is included in
Table 2. In reviewing the content of the 17 websites
included in this analysis, we found that Canadian medi-
cal tourism broker websites varied widely in scope, con-
tent, professionalism, and depth of information. Three
themes emerged from the thematic content analysis:
training and accreditation, risk communication, and
business dimensions. In this section we examine each
separately, identifying commonalities and differences
across the reviewed websites. We provide direct
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quotations from the reviewed websites to illustrate the
points raised in this section, and provide a number
beside each quote (e.g., #2) that corresponds to ‘com-
pany’ column in Table 1.
Training & Accreditation
Three types of accreditation and/or training were men-
tioned explicitly on brokers’ websites: (1) accreditation
of international hospitals; (2) training and accreditation
of international physicians; and (3) brokers’ own training
and accreditation. There was a certain degree of conti-
nuity between the three different types of training and
accreditation identified; 29.4% of websites did not men-
tion any specific credentials for the hospitals or physi-
cians they referred to nor did they display logos of
membership for their own brokerage. The remaining
70.6% varied in their level of professional accreditation
and communication of physicians’ qualifications.
The current gold standard for international hospitals
is Joint Commission International (JCI) accreditation
[14], and four of the websites stated specifically that
they only work with hospitals that are JCI accredited,
with one explaining: “JCI Accredited hospitals and
clinics must have the same or exceed standards com-
pared to the United States in clinical outcomes, infec-
tion rates, mortality rates and cleanliness.” The
majority of websites made no mention of any type of
specific hospital accreditation or certification, often
using vague descriptions as a substitute: “all rooms are
equipped with the very latest American and European
technology” (#9); “Our standards are as high, and can
exceed, those in the United States and United King-
dom” (#13); the hospitals use the “best technology
available on the market today” (#2). These examples
show the language that was commonly used to adver-
tise services, with superlative descriptors of the quality
of service and availability of new technologies appear-
ing on all websites.
Table 1 Medical Tourism Websites Included in Content
Analysis
Company Website Province of
Headquarters
1 http://timelymedical.ca British Columbia
2 http://www.meditours.org British Columbia
3 http://www.hsi-ssi.com/en Quebec
4 http://www.surgicaltourism.ca British Columbia
5 http://ecumedical.com/ecom.asp?* Ontario
6 www.healthvacations.ca None noted
7 http://www.debsonmedicaltourism.
com
Quebec
8 http://www.medextra.com Quebec
9 www.gosculptura.com Quebec
10 http://ihcproviders.com Ontario
11 http://passportmedical.com British Columbia
12 http://www.intermedglobal.com None noted
13 http://www.medipassionhealing.
com*
Quebec
14 http://www.
overseasmedicalservices.com*
Alberta
15 http://www.surgicalescape.com Alberta
16 http://www.choicemedicalservices.
com/
Manitoba
17 http://www.medasia.ca/ None noted
*Website used for study has either changed or been shut down since
September 2010
Table 2 Informational points contained on Canadian medical tourism brokers’ websites (N = 17)
Informational Points number of websites including
informational point
number of websites not including
informational point
Evidence of professional membership or certification 6 11
Information on foreign physicians (e.g., certifications,
training)
5 12
Explicit reference to foreign hospital accreditations 9 8
Explicit reference to foreign hospitals with JCI
accreditation
6 11
Explicit reference to “medical tourism” 12 5
Explicit reference to “broker” 0 17
Explicit reference to “facilitator” 7 10
Tourism services offered (e.g., arranging sightseeing) 10 7
Images of tourist attractions 7 10
Health risks (general - e.g., surgical risks) 9 8
Health risks (specific to medical tourism - e.g., post-
operative flight)
2 15
Patient testimonials 11 6
Pricing details 6 11
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In addition to indicators of the quality and accredita-
tion of foreign medical facilities, websites provided
information on the quality of the personnel in these
facilities through reference to their medical credentials.
Medical credentials of foreign physicians were men-
tioned on 41.2% of websites, sometimes in a generalized
way: “many of our doctors have been trained in the Uni-
ted States and the United Kingdom, right alongside the
physicians and surgeons that are working in the city in
which you live” (#13). Overall 52.9% of websites stated
that the company worked with international physicians
trained, at least in part, in either North America or Eur-
ope. Some websites not reporting credentials and train-
ing used other tactics to gain the trust of potential
medical tourists: “The life expectancy in Cuba is equal
to that found in developed countries... This type of sta-
tistic can only be achieved if the medical training and
procedures are similar to those of developed countries”
(#16).
While there was no single, dominant professional
organization or association to which the brokers
belonged, 35.3% of the websites featured symbols and
logos of some type on their main page, usually repre-
senting membership in various organizations (e.g.,
MTA, Better Business Bureau, International Medical
Travel Association, Medical Travel and Health Quality
Alliance). Demonstrations of certification, rather than
simply membership, on the websites were rare, with
only one website displaying the logo of the MTA certifi-
cation for brokers. It is worth noting that the MTA
membership logo is extremely similar to the certification
logo (the caduceus) with the exception of the word
“member” instead of “certification,” a distinction which
may not be apparent or have meaning to website visi-
tors. One other site included a symbol for an accrediting
agency, the Medical Travel and Health Tourism Quality
Alliance, which certifies brokers to be either a Certified
Medical Concierge or a Certified International Patient
Manager.
Risk Communication
A detailed search for any mention of risk on the
reviewed websites revealed that 47.1% made no general
or specific mention of risks at all. Of the 9 websites
that did address risk, only two mentioned any specific
risks associated with medical tourism, and these risks
were mentioned only in order to illustrate how, by
using a broker, they would be eliminated. Two sites
mentioned that there was a small risk involved in
obtaining a medical procedure, but were careful to
separate that risk from any risks associated with travel-
ing by reminding the patient that the same risk was
involved with the medical procedure if done in the
home country.
Risk of DVT due to post-operative travel was men-
tioned on two websites, but only in a context that
implied that neither company’s patients would have an
increased risk of DVT due to their short flights. For
example, a brokerage that only arranges for medical
tourism between Canada and the United States lists sev-
eral risks of traveling to a country outside of North
America for surgery, including DVT due to long-haul
flights. Their website provides a good example of how
careful wording was often used on when discussing risk:
“In the unlikely event of a complication during surgery,
which is unrelated to the reason for traveling to the
United States for medical care, the hospital will stabilize
the patient and send him/her back to Canada by ambu-
lance” (#1). Another example of careful wording is: “As
with any other surgical procedure, there are risks and
complications involved which are always measured. Cer-
tain risks depend on the individual surgeon and are
avoided without being acknowledged due to the sur-
geon’s expertise” (#9).
Discussion of negative outcomes and risks occurred
most often on the Frequently Asked Question or Dis-
claimer sections of websites, and only 17.6% addressed
possible negative outcomes. Such discussions appeared
to be aimed at reassuring potential clients, as shown in
this example: “As with any medical procedure at home
or away, there is always a small chance of a complica-
tion, so one should always plan for this eventuality.
That is why medical complication insurance is avail-
able...so that you can have peace of mind” (#11). While
most websites provided minimal overviews of the possi-
ble negative outcomes to medical tourism, the majority
had many examples of positive outcomes. One way this
was done was through the inclusion of patient testimo-
nials, where 70.6% of the websites contained at least one
personal statement from a former patient or from a
physician abroad. One company promised to put inter-
ested clients personally in touch with former clients for
a live testimonial experience.
Business Dimensions
Not surprisingly, websites conveyed information about
the broker’s business to potential medical tourists. One
of the business dimensions covered pertained to brokers’
involvement in follow up care, with 52.9% of the web-
sites promising quality follow-up care upon return
home. While those that did not make this promise typi-
cally did not address follow up care at all, one explicitly
stated that the brokerage had no responsibility in over-
seeing such care, stating that: “once arrangements have
been made to the mutual satisfaction of our client and
their physician, we have no ongoing involvement in the
doctor-patient relationship” (#1). For the brokers who
were involved in arranging for it, follow up care services
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varied between companies. These services included
arranging phone calls between the patient and the spe-
cialist abroad, having a report sent to the home physi-
cian, organizing rehabilitation, telehealth consultations,
and answering questions. It was often unclear whether
these services would come at an additional cost to the
patient.
Medical tourism is often associated with price savings
for patients. Nonetheless, only 29.4% of the websites
included specific prices for various treatments. When
sites did not list their prices, they often included percen-
tages representing the average savings a tourist could
expect. For example, one website stated that “if you
have received quotes in America for $10,000, you can
expect the same procedure to cost between $2,500 and
$5,000” (#13) while another noted that “care comes at a
cost that is 40-80% lower than the cost of the same pro-
cedures in the United States” (#6). It is interesting to
note that United States dollars were quoted in these
examples despite the fact that these companies were
operating in Canada, although references to faster wait
times for procedures typically quoted Canadian averages.
For example, a website listed their services as being “4-
10 times faster than in Canada” (#6).
The large majority (70.6%) of the brokers branded
themselves as being involved in the business of ‘medical
tourism’ via their websites. Brokers that did not use the
medical tourism label instead used labels such as: medical
travel, healthcare management, private pay medical ser-
vices, and travel for health services. This divide in brand-
ing or labelling extended to the images used on sites,
where medical tourism companies commonly depicted
images of tropical flowers and palm trees, images of cele-
brations and festivals that occur in destination countries,
and pictures of beach and ocean views, while sites not
adopting the medical tourism label had little or no tour-
ism-related imagery and were thus not marketing the
tourism dimensions of international patient travel.
The term ‘broker’ or ‘brokerage’ was not used at all in
the sample of reviewed websites. Meanwhile, this term
is widely used in the academic and popular literature
regarding medical tourism when characterizing these
businesses and the services they offer [27-29]. The term
that appeared most frequently (47.1%) was ‘facilitator’,
and it appeared in a variety of permutations, including
‘medical travel facilitator’, ‘health-medical tourism facili-
tator’, and ‘medical tourism facilitator.’ Other descrip-
tors included ‘medical tourism service provider’, ‘referral
agency’, ‘medical tourism advocates’, ‘international
patient support’ and ‘medical tourism guidance.’
Discussion
Medical tourism brokers play an important role in the
medical tourism industry and have helped make
traveling abroad for medical care a viable option for
more people than ever before [6,7,11,12,14]. Through
our assessment of 17 Canadian brokers’ websites we
have been able to gain an understanding of the quantity
and quality of online information available to persons
using Canadian brokers. Their websites were clearly
designed to sell brokers’ services to potential medical
tourists. For this reason, the information provided
through these websites is geared more toward promo-
tional ends rather than helping to inform patients of the
full range of their treatment options or communicating
the potential risks inherent in medical tourism. Mason
and Wright identified a similar trend in their analysis of
66 international medical tourism websites (which
included broker and non-broker sites) [12]. Crooks et
al.’s thematic content analysis of promotional brochures
from medical tourism hospitals in India also revealed a
strong emphasis on characterizing credentials and
accreditation, services, and specializations over issues
such as cost and follow up care [30]. When the findings
of our analysis are considered in relation to these other
studies it becomes clear that a lack of emphasis on risk
communication in medical tourism marketing materials
is not specific to Canadian brokers but, instead, is more
likely an industry-wide phenomenon.
The findings shared above highlight many issues that
hold significant implications for Canadian patients’
informed consent when engaging in medical tourism,
four of which we expand upon in this section. First, our
review revealed that only 2 of the 17 brokerages had
been certified by an accrediting body, while many web-
sites had various logos signifying membership with the
MTA and other groups. While these logos are meant to
assure the patient of the broker’s professional status,
they do not typically guarantee any particular standard
of operation. The risk generated by this lack of standar-
dization is that it allows brokers with lower standards
and who do less to mitigate and inform patients of risks
to operate amidst competent brokers, with little means
of differentiating between the two [6,14]. This lack of
clarity may compromise a patient’s ability to make
informed decisions regarding their treatment, thereby
ultimately compromising informed consent, and puts
them in a position where they may be unsure of the
consequences of deciding to use a particular broker to
book a procedure abroad.
A second issue related to informed consent emerging
from the findings pertains to the role of terminology in
clarifying what services patients are purchasing. More
specifically, the terminology chosen by the brokers may
factor into how a patient views their services. The term
‘medical tourism’ has been described as that which is
most commonly used within the industry and by the
media [31], and the majority of the brokers in this study
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adopted it on their websites. Bioethicists and other
scholars have observed that the term itself may be pro-
blematic; the word ‘tourism’ evokes images of beaches
and sightseeing, potentially undermining the seriousness
of the medical procedure in the patient’s mind
[19,31,32]. As such, the term may under-represent the
risks involved in going abroad for medical care. Related
to this is a need to develop standardized role terminol-
ogy. The websites we reviewed uniformly avoided the
term ‘broker’ that is so oft used in popularized contexts.
This is likely deliberate; the term ‘facilitator’ evokes the
image of a helper, someone making life easier, while the
term ‘broker’ brings to mind the world of business and
money-making. Moreover, a ‘facilitator’ may be seen
more to have the patient’s interests at heart, thus redu-
cing risks, while a ‘broker’ might be seen as engaging in
more mercenary, risk-taking behaviour, making the bro-
ker’s perceived role an important element in the com-
munication and understanding of risk.
The messages conveyed by the Canadian medical tour-
ism broker websites we reviewed were overwhelmingly
positive, which raises a third issue regarding informed
consent. Positive, if not glowing, patient testimonials
were more frequently present than not, while acknowl-
edgement of risks were notably rare. This finding is con-
sistent with those of other studies that have examined
promotional information in medical tourism and have
ultimately questioned the trustworthiness of what is
being reported and its ability to support patient deci-
sion-making [7,14,30]. While it is understandable that
medical tourism brokers, in an effort to portray their
product in the most favourable light possible, may be
reluctant to address the issue of risk on their websites,
this omission is potentially misleading and unethical.
Brokers may be inclined to leave the discussion of risk
until later in the process of arranging care abroad or
until they meet with the patient in person, but the web-
site is likely the first and possibly main source of infor-
mation for many patients [7]. In order to make a truly
informed decision about whether or not to proceed with
arrangements - and thus ultimately to give informed
consent for medical care abroad - they ought to have
access to balanced and accurate risk information at the
beginning of their decision making process.
The final issue related to informed consent emerging
from the findings of our thematic content analysis
relates to information, or the lack thereof, about follow
up care on the reviewed websites. Generally, follow up
care details were rarely included in brokers’ websites.
This is concerning because when Canadians undergo
surgery domestically, follow up care is commonly coor-
dinated between the hospital and the family physician
and is generally organized on behalf of the patient. Med-
ical tourism disrupts this standard practice [33,34].
Medical tourists will inevitably be moving between two
different health care systems that are not connected,
making it unclear exactly who should be responsible for
organizing check-ups and rehabilitation after the proce-
dure [6]. If follow up care details are not shared with
the patient initially, or if it is not noted explicitly that
patients are expected to arrange for their own follow up
care upon return home, they may decide to proceed
with purchasing medical care abroad while being una-
ware of the amount of care needed once they have
returned home. This poses a risk to medical tourists on
many fronts. It may negatively impact their health
should they not be in a position to navigate their home
health care system upon return home without the sup-
port or referral of a domestic surgeon [1]. It may also
lessen the quality of care patients receive upon returning
home in that they may underestimate the informational
needs of service providers thereby compromising care
quality. One way to address these concerns is to encou-
rage patients to communicate their plans to engage in
medical tourism to their family doctors before going
abroad as this may lead to consideration of follow up
care before departure [30]. Such patients will have a
broader range of sources from which they are gathering
information and will be able to come to a more
informed decision on whether or not they want to con-
sent to the procedure.
As we have noted, ethical and legal debates about the
regulation of the medical tourism industry exist in the
scholarly literature [14,35]. In our own research we have
found that Canadian medical tourism brokers believe
they have significant roles to play not only within the
industry but to medical tourists specifically, particularly
to ensure these patients’ safety [6]. The provision of
informed consent falls naturally within the roles they
espouse toward patients, but brokers’ perspectives on
this needs to be sought in order to ascertain whether or
not they agree in both principle and practice.
The Canadian government is involved in protecting
Canadian patients and ensuring their health through the
public health care system, and as such is well positioned
to address some of the issues that hold implications for
medical tourists’ informed consent that we have identi-
fied in this analysis. As brokers are involved in patient
care, directly or indirectly, and have a unique relation-
ship with the medical tourist, it would seem fitting that
the government take steps to monitor their work and
ensure they are meeting standards of care for patients.
Turner has made a broad call for regulatory involve-
ment by the American government in regard to medical
tourism brokerage companies operating in the United
States [14]. While the insights gained from our study of
broker websites does not support the full range of regu-
lations suggested by Turner, some of which would not
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protect patient choice (e.g., restricting brokers from
advertising services not approved in their local jurisdic-
tions), certain areas of intervention are justified by our
findings. More specifically, Canadian government inter-
vention in the areas of medical tourism brokers’ involve-
ment in follow up care and risk communication seems
warranted given the lack of apparent consideration
given to these domains by brokers currently as assessed
by our review of their websites. Such intervention need
not be complex, and could include developing informa-
tional resources for Canadian medical tourism brokers
or requiring brokers to disclose risk information on
their websites. In general, government regulators have
an obligation to oversee and set standards for the infor-
mation available to potential medical tourists in order to
ensure that the risks of this practice are understood and
that false, misleading, or unverifiable claims are not
made by brokers that would unethically undermine
patient informed consent [36].
Limitations
One limitation is that the information we used to draw
conclusions about brokers’ business practices was limited
to that which was found on their websites. We are aware
that many brokers use brochures, information booklets,
e-mails, and face-to-face conversations in addition to
their websites as means of disseminating information to
their clients; these other forms of communication may
provide valuable information not found on the websites.
That being said, we do believe that the websites are a key
source of information and that they play a significant role
in patients’ decision-making processes and formation of
initial impressions when considering medical tourism
and so warrant explicit consideration.
Another limitation is that the sample of websites
reviewed may not be exhaustive of Canada-based bro-
kers. We made all reasonable efforts to identify medical
tourism brokerages based in Canada with English-lan-
guage websites; however, it is possible that there are
more companies currently operating in Canada than
were identified in this study (e.g., those operating exclu-
sively in French). Additionally, we did not include com-
panies whose primary business was standard travel and
tourism but who also had a medical tourism compo-
nent. Nonetheless, we believe the included websites
serve as a representative sample of medical tourism bro-
kers in Canada and certainly those most accessible to
potential medical tourists online. It is worth noting that
three of the websites reviewed have been subsequently
shut down or are under construction, an issue similarly
encountered by Cormany and Baloglu in their analysis
of international medical travel websites [29]. Our analy-
sis, therefore, is of a representative snapshot of an evol-
ving industry.
Conclusions
Our review of 17 Canadian medical tourism broker web-
sites revealed that medical tourists may be exposed to
incomplete or misleading information about the risks
involved with this practice. Training and accreditation
of these brokers was uneven and the symbols of profes-
sionalization found on these websites were more likely
to confuse than enlighten potential medical tourists.
The terminology used by brokers may obfuscate their
roles, including the place of tourism activities in medical
tourism. Broker websites were also found generally not
to provide information on the risks of this practice and
information on the brokers’ business, including pricing
and the provision of follow up care. These shortcomings
are matters of grave ethical concern as they threaten the
ability of patients to make informed decisions regarding
their medical care.
Our findings support increased government oversight
of brokers in the name of improving the communication
of risks to patients and better informing their choice
regarding whether or not to engage in medical tourism,
thereby ultimately enhancing informed consent. Protect-
ing patient choice justifies some previously called-for
interventions, including government review of broker
accreditors, oversight of the information provided on
websites, and requirements for transparency regarding
the provision of follow up care and legal liability [14,27].
Other regulations are not justified by an interest in
informed consent and may undermine patient choice.
Creating support for the development of oversight
mechanisms for the medical tourism industry will be
aided by continued study of medical tourism brokers,
including other country-specific studies like our own
and reviews of the information provided by brokers
beyond their publicly accessible websites.
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